Skip to content

Clinical trials

Altitude Sickness trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Altitude Sickness Phase: Not applicable Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20064
20071
20084
20111
20122
20131
20151
201611
20172
201815
20196
20204
20214
20227
202316
20248
20254
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Unknown status23
Not yet recruiting17
Recruiting10
Active, not recruiting1
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich23
Silvia Ulrich Somaini14
Heidelberg University4
Insel Gruppe AG, University Hospital Bern3
Macao Polytechnic University3
Massachusetts General Hospital3
Mona Lichtblau3
United States Army Research Institute of Environmental Medicine3
University of Colorado, Denver3
Institut de Formation et de Recherche en Médecine de Montagne2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Altitude Sickness120
Hypoxia45
Hypertension, Pulmonary25
Pulmonary Arterial Hypertension10
Respiratory Aspiration5
Sleep Apnea Syndromes4
Dyspnea3
Familial Primary Pulmonary Hypertension3
Anemia, Iron-Deficiency2
Breast Neoplasms2

Trials

Showing 26 to 50 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.